This is a Validated Antibody Database (VAD) review about human CD82, based on 6 published articles (read how Labome selects the articles), using CD82 antibody in all methods. It is aimed to help Labome visitors find the most suited CD82 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD82 synonym: 4F9; C33; GR15; IA4; KAI1; SAR2; ST6; TSPAN27; CD82 antigen; C33 antigen; inducible membrane protein R2; kangai 1 (suppression of tumorigenicity 6, prostate; CD82 antigen (R2 leukocyte antigen, antigen detected by monoclonal and antibody IA4)); metastasis suppressor Kangai-1; tetraspanin-27; tspan-27

BioLegend
mouse monoclonal (ASL-24)
  • other; human; 500 ug/ml; fig 1
BioLegend CD82 antibody (BioLegend, 342102) was used in other on human samples at 500 ug/ml (fig 1). J Extracell Vesicles (2016) ncbi
mouse monoclonal (ASL-24)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BioLegend CD82 antibody (BioLegen d, 342104) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (ASL-24)
  • flow cytometry; human; fig 2
BioLegend CD82 antibody (BioLegend, 342104) was used in flow cytometry on human samples (fig 2). Leukemia (2015) ncbi
mouse monoclonal (ASL-24)
  • flow cytometry; human; fig 1
BioLegend CD82 antibody (Biolegend, ASL-4) was used in flow cytometry on human samples (fig 1). J Virol (2015) ncbi
mouse monoclonal (ASL-24)
In order to study the role of alpha-4 integrin in the mechanism by which CD82 modulates cell adhesion, BioLegend CD82 antibody (BioLegend, ASL-24) was used . Mol Biol Cell (2014) ncbi
Abcam
rabbit polyclonal
  • western blot; human
In order to study the role of alpha-4 integrin in the mechanism by which CD82 modulates cell adhesion, Abcam CD82 antibody (Abcam, ab66400) was used in western blot on human samples . Mol Biol Cell (2014) ncbi
R&D Systems
mouse monoclonal (423524)
  • other; human; fig 2
In order to characterize capabilities and potentials of extracellular vesicle (EV) array, R&D Systems CD82 antibody (R&D Systems, MAB4616) was used in other on human samples (fig 2). J Extracell Vesicles (2015) ncbi
Articles Reviewed
  1. Belov L, Matic K, Hallal S, Best O, Mulligan S, Christopherson R. Extensive surface protein profiles of extracellular vesicles from cancer cells may provide diagnostic signatures from blood samples. J Extracell Vesicles. 2016;5:25355 pubmed publisher
  2. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  3. Nishioka C, Ikezoe T, Takeuchi A, Nobumoto A, Tsuda M, Yokoyama A. The novel function of CD82 and its impact on BCL2L12 via AKT/STAT5 signal pathway in acute myelogenous leukemia cells. Leukemia. 2015;29:2296-306 pubmed publisher
  4. Jørgensen M, Bæk R, Varming K. Potentials and capabilities of the Extracellular Vesicle (EV) Array. J Extracell Vesicles. 2015;4:26048 pubmed publisher
  5. Lambelé M, Koppensteiner H, Symeonides M, Roy N, Chan J, Schindler M, et al. Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells. J Virol. 2015;89:3247-55 pubmed publisher
  6. Termini C, Cotter M, Marjon K, Buranda T, Lidke K, Gillette J. The membrane scaffold CD82 regulates cell adhesion by altering α4 integrin stability and molecular density. Mol Biol Cell. 2014;25:1560-73 pubmed publisher